nach oben

Erschienen in:

01.03.2018 | Clinical study

Carvedilol effective for cardiotoxicity prevention?

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Auszug

Although the attempted prevention of anthracycline-induced cardiotoxicity with carvedilol did not significantly impact left ventricular ejection fraction (LVEF) measurements, according to study results reported in the Journal of the American College of Cardiology, troponin I (TnI) elevation was attenuated and fewer patients developed diastolic dysfunction, "suggesting a protective effect of carvedilol in myocardial injury". …

Carvedilol Effect in Preventing Chemotherapy Induced Cardiotoxicity (CECCY) trial; NCT01724450

Avila MS, et al. Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity. Journal of the American College of Cardiology : 11 Mar 2018. Available from: URL: http://dx.doi.org/10.1016/j.jacc.2018.02.049

Titel: Carvedilol effective for cardiotoxicity prevention?
Publikationsdatum: 01.03.2018
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-018-43409-z

Springer Medizin

Carvedilol effective for cardiotoxicity prevention?

Auszug

Weitere Artikel der Ausgabe 1/2018

Sorafenib/vandetanib

Dipyrone

Diazepam overdose

Docetaxel

Contusugene-ladenovec

Hydroxychloroquine/prednisone

Springer Medizin

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sorafenib/vandetanib

Dipyrone

Diazepam overdose

Docetaxel

Contusugene-ladenovec

Hydroxychloroquine/prednisone